Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: a multi-model studyRebecca K. Borchering, Jeffrey Shaman, Claire P. Smith et al.|The Lancet Regional Health - Americas|2022Cited by 27
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studyRebecca K. Borchering, Guido España, Luke C. Mullany et al.|medRxiv|2022Cited by 23